432 related articles for article (PubMed ID: 19284480)
1. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
Chan CH; Ramirez-Montealegre D; Pearce DA
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
[TBL] [Abstract][Full Text] [Related]
2. Defective lysosomal arginine transport in juvenile Batten disease.
Ramirez-Montealegre D; Pearce DA
Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
[TBL] [Abstract][Full Text] [Related]
3. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
[TBL] [Abstract][Full Text] [Related]
5. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
6. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
Vitiello SP; Wolfe DM; Pearce DA
Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
[TBL] [Abstract][Full Text] [Related]
7. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
[TBL] [Abstract][Full Text] [Related]
8. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
[TBL] [Abstract][Full Text] [Related]
9. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
[TBL] [Abstract][Full Text] [Related]
11. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
Ding SL; Tecedor L; Stein CS; Davidson BL
Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical localization of the Batten disease (CLN3) protein in retina.
Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
[TBL] [Abstract][Full Text] [Related]
13. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
14. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
[TBL] [Abstract][Full Text] [Related]
15. Moving towards therapies for juvenile Batten disease?
Cooper JD
Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
[TBL] [Abstract][Full Text] [Related]
16. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
17. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
[TBL] [Abstract][Full Text] [Related]
18. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
[TBL] [Abstract][Full Text] [Related]
19. A murine model for juvenile NCL: gene targeting of mouse Cln3.
Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM
Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119
[TBL] [Abstract][Full Text] [Related]
20. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
Xiong J; Kielian T
J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
